Announcement under Regulation 30 of SEBI (LODR) Regulations, 2015 for the Appointment of Auditors
BAJAJHCARE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Bajaj Healthcare reported FY2026 audited standalone results with revenue from operations growing 12.6% to Rs 61,103.14 lakhs from Rs 54,260.24 lakhs. However, profit after tax from continuing operations fell 50% to Rs 2,131.04 lakhs from Rs 4,292.88 lakhs due to a Rs 3,324.66 lakh exceptional item — income reversal from a technical know-how arrangement with a Middle East customer affected by regional instability. Total comprehensive income for the year was Rs 1,637.58 lakhs versus Rs 4,086.56 lakhs in the prior year. The Board recommended a final dividend of Rs 1.50 per share (30% on Rs 5 face value), subject to shareholder approval. The statutory auditor issued an unmodified (clean) opinion. The company also appointed M/s. JCR & Co. LLP as internal auditors for FY2026-27 and reappointed M/s. V.J. Talati & Co. as cost auditors.
Despite solid revenue growth, the large exceptional item severely impacted profitability, resulting in a 60% decline in total comprehensive income for the year. The clean audit opinion provides some comfort, but investors may react negatively to the profit decline unless the Middle East-related reversal is viewed as a one-time event.